Merck KGaA Sponsored ADR (MKKGY)
OTC
Closed
Oct 8, 2026
Day's Range
30.4152 wk Range
23.73Overview - MKKGY - Merck KGaA Sponsored ADR
Key Statistics
Valuation
Enterprise Value
85.63B
P/E (Trailing)
‪24.89‬
P/E (Forward)
‪15.20‬
PEG Ratio
‪-1.00‬
Price / Sales (TTM)
‪3.17‬
Price / Book
‪1.95‬
EV / EBITDA
‪13.64‬
Profitability
Profit Margin
‪11.21%‬
Operating Margin
‪13.85%‬
Return on Assets
‪4.65%‬
Return on Equity
‪8.13%‬
Ownership
Shares Outstanding
646.21M
Float
644.34M
Held by Insiders
‪0.00%‬
Held by Institutions
‪0.01%‬
Price stats
Beta
‪0.80‬
50-Day Avg
‪31.81‬
200-Day Avg
‪29.56‬
Dividends
Payout Ratio
‪40.42%‬
Frequency
Annual
Analyst Consensus
2 analysts
Average price target
‪$ 36.02‬Shariah Compliance
Report Date: Feb 17, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - MKKGY - Merck KGaA Sponsored ADR
Peers - MKKGY - Merck KGaA Sponsored ADR
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on OTC.
Profile Summary - MKKGY - Merck KGaA Sponsored ADR
About
Merck KGaA Sponsored ADR represents the American Depository Receipt for Merck KGaA, a global science and technology company based in Darmstadt, Germany. The ADR allows US investors to buy shares of the German company on US exchanges, facilitating cross-border investment. Merck KGaA operates in the healthcare, life…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
